T A Bogush Selected Research

flumecinol

1/2002

[The drop in toxicity and the rise in the effectiveness of antineoplastic chemotherapy by correcting the activity of liver monooxygenases: from the experiment to the clinical practice].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

T A Bogush Research Topics

Disease

21	Neoplasms (Cancer) 05/2019 - 09/2001
12	Breast Neoplasms (Breast Cancer) 05/2019 - 01/2001
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 01/2003
4	Ovarian Neoplasms (Ovarian Cancer) 09/2018 - 01/2014
3	Lung Neoplasms (Lung Cancer) 01/2012 - 01/2003
2	Neoplasm Metastasis (Metastasis) 01/2014 - 01/2013
1	Kidney Neoplasms (Kidney Cancer) 04/2022
1	Genomic Instability 05/2019
1	Ehrlich Tumor Carcinoma 05/2016
1	Ascites 05/2016
1	Necrosis 01/2012
1	Adenocarcinoma of Lung 01/2012
1	Brain Neoplasms (Brain Tumor) 01/2009
1	Colorectal Neoplasms (Colorectal Cancer) 01/2009
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2009
1	Colonic Neoplasms (Colon Cancer) 01/2002
1	Aneuploidy (Aneuploid) 11/2001
1	Virus Diseases (Viral Diseases) 01/2001

Drug/Important Bio-Agent (IBA)

11	Estrogen ReceptorsIBA 05/2019 - 03/2007
8	Tamoxifen FDA LinkGeneric 05/2019 - 01/2001
6	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2007 - 01/2002
5	Estrogen Receptor Modulators (Antiestrogen)IBA 05/2019 - 01/2009
4	Estrogens (Estrogen)FDA Link 05/2019 - 12/2010
4	Proteins (Proteins, Gene)FDA Link 01/2015 - 01/2003
3	PlatinumIBA 09/2018 - 01/2003
3	Biological ProductsIBA 08/2016 - 01/2009
3	Estrogen Receptor betaIBA 01/2012 - 01/2009
2	GenisteinIBA 05/2019 - 01/2003
2	Estrogen Receptor alphaIBA 09/2018 - 01/2009
2	Pharmaceutical PreparationsIBA 08/2016 - 01/2012
2	Cytostatic AgentsIBA 05/2016 - 09/2001
2	Cisplatin (Platino)FDA LinkGeneric 05/2016 - 01/2003
2	AntibodiesIBA 01/2012 - 01/2009
2	SuspensionsIBA 01/2009 - 05/2003
2	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2003 - 01/2003
2	Sodium AzideIBA 05/2003 - 01/2003
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2001 - 09/2001
2	Mesna (Coenzyme M)FDA LinkGeneric 11/2001 - 09/2001
1	BRCA1 ProteinIBA 05/2019
1	ApigeninIBA 05/2019
1	Hormones (Hormone)IBA 05/2019
1	Fulvestrant (Faslodex)FDA Link 05/2019
1	SteroidsIBA 05/2019
1	Phytoestrogens (Phytoestrogen)IBA 05/2019
1	taxaneIBA 09/2018
1	ParaffinIBA 01/2017
1	Digoxin (Digitek)FDA LinkGeneric 05/2016
1	Cardiac GlycosidesIBA 05/2016
1	Messenger RNA (mRNA)IBA 01/2015
1	Protein Isoforms (Isoforms)IBA 01/2012
1	Carrier Proteins (Binding Protein)IBA 01/2010
1	Monoclonal AntibodiesIBA 01/2010
1	Carboplatin (JM8)FDA LinkGeneric 01/2003
1	AnthracyclinesIBA 01/2003
1	Adenosine Triphosphate (ATP)IBA 01/2003
1	Verapamil (Calan)FDA LinkGeneric 01/2003
1	flumecinolIBA 01/2002
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2002
1	Multidrug Resistance-Associated ProteinsIBA 01/2002
1	Antineoplastic Agents (Antineoplastics)IBA 01/2001

Therapy/Procedure

6	Therapeutics 04/2022 - 01/2009
6	Drug Therapy (Chemotherapy) 08/2016 - 01/2001
1	Adjuvant Chemotherapy 09/2018
1	Intraperitoneal Injections 05/2016
1	Aftercare (After-Treatment) 05/2003